Financials

Discussions Technicals Seasonals

0RGO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to EUROPEAN MEDICAL SOLUTION NPV (POST SPLIT) operating, investing, and financing activities

0RGO free cash flow for H1 24 is -1.18 M EUR. For 2023, 0RGO free cash flow was -4.84 M EUR and operating cash flow was -2.27 M EUR.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—